Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Obstetric use of misoprostol: innovations, evidence, controversy and global health perspectives

Hofmeyr, George Justus

Publication date

April 2015

Abstract

Thesis (D.Sc.)--University of the Witwatersrand, Faculty of Health Sciences, 2012

Extracted data

Related items

Randomized comparative study of safety and efficacy of oral and vaginal misoprostol in the termination of second trimester pregnancy at tertiary care institution

S., Lujimmala
E., Anitha

October 2017

Background: A prospective randomized study was conducted in 72 pregnant women, with gestational peri...

Survey on the use of misoprostol for induction of labour among Obstetricians in the west African sub region

Idrisa, A
Audu, BM
Kullima, AA

February 2013

Context: Wide spread use of misoprostol is increasingly commoner in our obstetrics and gynaecologica...

Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage

Chu, Christina S
Brhlikova, Petra
Pollock, Allyson M

January 2012

SUMMARY This article describes and critically appraises clinical trials assessing misoprostol effect...

The role of Misoprostol in the third stage of labour

Nooh, Randa Mohammed S

January 2000

Postpartum haemorrhage (PPH) is a leading cause of maternal death in both developing and industriali...

Misoprostol for the Prevention of Postpartum Hemorrhage and Reduction of Maternal Mortality During Home Birth Deliveries in Developing Countries

Townley, Kateland

February 2018

A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...

Misoprostol for postpartum hemorrhage: Moving from evidence to practice

Starrs, Ann
Winikoff, Beverly

January 2012

AbstractClinical and operational evidence indicates that misoprostol is a safe and effective technol...

Misoprostol: An emerging technology for women\u27s health—Report of a seminar

Shannon, Caitlin S.
Winikoff, Beverly

January 2004

On May 7–8, 2001, the Population Council and the Center for Reproductive Health Research & Policy of...

Reduction in Septic Abortion Following The Introduction of Misoprostol in Kumasi, Ghana

Ogu, Kiki

May 2019

Medical Schoolhttps://deepblue.lib.umich.edu/bitstream/2027.42/149408/1/KikiOgu_1.pd

Misoprostol for prevention and treatment of postpartum haemorrhage : a systematic review

Olefile, Kabelo M.
Khondowe, Oswell
M'Rithaa, Doreen

April 2013

Publication of this article was funded by the Stellenbosch University Open Access Fund.The original ...

Community-based misoprostol for the prevention of post-partum haemorrhage: A narrative review of the evidence base, challenges and scale-up

Hobday, K
Hulme, J
Belton, S
Homer, CSE
Prata, N

August 2018

© 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. Achieving Sustainable Developm...

Misoprostol and teratogenicity: Reviewing the evidence

Philip, Neena
Shannon, Caitlin S.
Winikoff, Beverly

January 2003

Misoprostol, a prostaglandin E1 analog marketed as Cytotec® for the prevention and treatment of gast...

A comparative study of efficacy of two different regimens of vaginal misoprostol in first trimester termination of pregnancy in a tertiary care hospital

Ramya S. P.
Gopalan, Ushadevi

February 2023

Background: Misoprostol has been authorised as an effective medication for termination of pregnancy ...

Update on the use of misoprostol in current obstetric practice

Ngassa, PC

October 2006

Misoprostol is one of the most important drugs in obstetric practice today. However, because of its ...

Randomized comparative study of safety and efficacy of oral and vaginal misoprostol in the termination of Second trimester pregnancy over a period of one Year at tertiary care institution

Luijimmala, S

April 2014

OBJECTIVES: A prospective randomized study was conducted in 72 pregnant women, with the gestationa...

Global Abortion And Marketing Challenges For Misoprostol (Cytotec): The Future Of Womens Health

Antommattei, Osvaldo
Khanfar, Nile M.
Mujtaba, Bahaudin G.

January 2009

This paper provides an overview of the controversial drug Misoprostol (Cytotec) and its importance f...

Randomized comparative study of safety and efficacy of oral and vaginal misoprostol in the termination of second trimester pregnancy at tertiary care institution

S., Lujimmala
E., Anitha

October 2017

Background: A prospective randomized study was conducted in 72 pregnant women, with gestational peri...

Survey on the use of misoprostol for induction of labour among Obstetricians in the west African sub region

Idrisa, A
Audu, BM
Kullima, AA

February 2013

Context: Wide spread use of misoprostol is increasingly commoner in our obstetrics and gynaecologica...

Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage

Chu, Christina S
Brhlikova, Petra
Pollock, Allyson M

January 2012

SUMMARY This article describes and critically appraises clinical trials assessing misoprostol effect...

The role of Misoprostol in the third stage of labour

Nooh, Randa Mohammed S

January 2000

Postpartum haemorrhage (PPH) is a leading cause of maternal death in both developing and industriali...

Misoprostol for the Prevention of Postpartum Hemorrhage and Reduction of Maternal Mortality During Home Birth Deliveries in Developing Countries

Townley, Kateland

February 2018

A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...

Misoprostol for postpartum hemorrhage: Moving from evidence to practice

Starrs, Ann
Winikoff, Beverly

January 2012

AbstractClinical and operational evidence indicates that misoprostol is a safe and effective technol...

Misoprostol: An emerging technology for women\u27s health—Report of a seminar

Shannon, Caitlin S.
Winikoff, Beverly

January 2004

On May 7–8, 2001, the Population Council and the Center for Reproductive Health Research & Policy of...

Reduction in Septic Abortion Following The Introduction of Misoprostol in Kumasi, Ghana

Ogu, Kiki

May 2019

Medical Schoolhttps://deepblue.lib.umich.edu/bitstream/2027.42/149408/1/KikiOgu_1.pd

Misoprostol for prevention and treatment of postpartum haemorrhage : a systematic review

Olefile, Kabelo M.
Khondowe, Oswell
M'Rithaa, Doreen

April 2013

Publication of this article was funded by the Stellenbosch University Open Access Fund.The original ...

Community-based misoprostol for the prevention of post-partum haemorrhage: A narrative review of the evidence base, challenges and scale-up

Hobday, K
Hulme, J
Belton, S
Homer, CSE
Prata, N

August 2018

© 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. Achieving Sustainable Developm...

Misoprostol and teratogenicity: Reviewing the evidence

Philip, Neena
Shannon, Caitlin S.
Winikoff, Beverly

January 2003

Misoprostol, a prostaglandin E1 analog marketed as Cytotec® for the prevention and treatment of gast...

A comparative study of efficacy of two different regimens of vaginal misoprostol in first trimester termination of pregnancy in a tertiary care hospital

Ramya S. P.
Gopalan, Ushadevi

February 2023

Background: Misoprostol has been authorised as an effective medication for termination of pregnancy ...

Update on the use of misoprostol in current obstetric practice

Ngassa, PC

October 2006

Misoprostol is one of the most important drugs in obstetric practice today. However, because of its ...

Randomized comparative study of safety and efficacy of oral and vaginal misoprostol in the termination of Second trimester pregnancy over a period of one Year at tertiary care institution

Luijimmala, S

April 2014

OBJECTIVES: A prospective randomized study was conducted in 72 pregnant women, with the gestationa...

Global Abortion And Marketing Challenges For Misoprostol (Cytotec): The Future Of Womens Health

Antommattei, Osvaldo
Khanfar, Nile M.
Mujtaba, Bahaudin G.

January 2009

This paper provides an overview of the controversial drug Misoprostol (Cytotec) and its importance f...

Randomized comparative study of safety and efficacy of oral and vaginal misoprostol in the termination of second trimester pregnancy at tertiary care institution

S., Lujimmala
E., Anitha

October 2017

Background: A prospective randomized study was conducted in 72 pregnant women, with gestational peri...

Survey on the use of misoprostol for induction of labour among Obstetricians in the west African sub region

Idrisa, A
Audu, BM
Kullima, AA

February 2013

Context: Wide spread use of misoprostol is increasingly commoner in our obstetrics and gynaecologica...

Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage

Chu, Christina S
Brhlikova, Petra
Pollock, Allyson M

January 2012

SUMMARY This article describes and critically appraises clinical trials assessing misoprostol effect...